Concepedia

Johannes Sch�ller

JS

Statistics

Publications

2

Citations

712

H-Index

2

Active since

2000

Affiliations

Roche (Japan)(Current)

Roche (United Kingdom)

Rudolfinerhaus Hospital

Roche (Switzerland)

Johannes Sch�ller is an author at Roche (Japan) specializing in pharmacodynamics of anticancer agents, medicine, and pharmacology.

Publications per year

2000–2003

2

Publications

2

Preferential activation of capecitabine in tumor following oral administration to colorectal cancer patients

Johannes Sch�ller, Jim Cassidy, Étienne Dumont et al. · Cancer Chemotherapy and Pharmacology · 2000 · 666 citations

, , +14

Pharmacokinetics of capecitabine (Xeloda) in Japanese and Caucasian patients with breast cancer

Bruno Reigner, Toru Watanabe, Johannes Sch�ller et al. · Cancer Chemotherapy and Pharmacology · 2003 · 46 citations

, , +14

1–2 of 2